These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 349572)

  • 21. Metabolic changes induced by a nicotinic acid derivative in patients with obesity grades 1, 2 and 3.
    Santagostino A; Pagani G; Ballerio G; Porro T
    Panminerva Med; 1979; 21(3):111-26. PubMed ID: 554045
    [No Abstract]   [Full Text] [Related]  

  • 22. [The management of hyperlipoproteinemia with Liproreduct].
    Fenster R
    Ther Ggw; 1974 May; 113(5):813-24. PubMed ID: 4603893
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of sorbinicate and nicotinic acid on blood viscosity, red cell deformation and platelet function.
    Strano A; Novo S; Davì G; Avellone G; Mandalà V
    Pharmacol Res Commun; 1982 Jul; 14(7):639-48. PubMed ID: 7134249
    [No Abstract]   [Full Text] [Related]  

  • 24. [Arteriosclerosis--nicotinic acid therapy. 11. Nicotinic acid and tissue triglycerides].
    Fröberg SO
    Lakartidningen; 1971 Apr; 68(15):1773-5. PubMed ID: 5577253
    [No Abstract]   [Full Text] [Related]  

  • 25. On the absorption, distribution and excretion of sorbinicate in the rat and the monkey.
    Giachetti C; Mondino A; Silvestri S; Zanolo G; Bramanti G; Criscuoli M; Subissi A
    Arzneimittelforschung; 1982; 32(11):1433-6. PubMed ID: 6891249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Therapy of hyperlipemias with lipolytic drugs].
    Jover Sanz E; Paradinas Jiménez C; Corporales López L; Martínez Robles JV
    Rev Clin Esp; 1974 Jun; 133(5):447-50. PubMed ID: 4428087
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of sorbinicate on blood proteins and platelet aggregation in patients with coronary disease].
    Bonfiglioli D; Sommariva D; Rovelli L; Panigo F; Gatti P; Cialfi A; Grimoldi M; Cabrini E; Fasoli A
    Clin Ter; 1984 Jul; 110(2):111-8. PubMed ID: 6237851
    [No Abstract]   [Full Text] [Related]  

  • 28. Dissociation of the effects of nicotinic acid on vasodilatation and lipolysis by a prostaglandin synthesis inhibitor, indomethacin, in man.
    Kaijser L; Eklund B; Olsson AG; Carlson LA
    Med Biol; 1979 Apr; 57(2):114-7. PubMed ID: 376964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Arteriosclerosis and nicotinic acid therapy. 4. Nicotinic acid therapy].
    Ribom U
    Lakartidningen; 1971 Apr; 68(15):1750-2. PubMed ID: 5577246
    [No Abstract]   [Full Text] [Related]  

  • 30. [Activation of fibrinolysis after oral administration of D-glucitol-hexanicotinate. Preliminary data].
    Pinto A; Novo S; Avellone G; Vinci G
    Boll Soc Ital Cardiol; 1978; 23(4):641-5. PubMed ID: 757348
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of nicotinic acid administaation on plasma HGH, FFA and glucose in obese subjects and in hypopituitary patients.
    Irie M; Tsushima T; Sakuma M
    Metabolism; 1970 Nov; 19(11):972-9. PubMed ID: 5479511
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparative investigations on the effect of nicotinic acid alone and in association with a synthetic, heparin-like sulfated polyanion on fibrinolysis, platelet aggregation and lipidic fractions.
    Turazza G; Spreafico PL; Frandoli G
    Arzneimittelforschung; 1973 May; 23(5):654-7. PubMed ID: 4575777
    [No Abstract]   [Full Text] [Related]  

  • 33. Nocturnal inhibition of lipolysis in man by nicotinic acid and derivatives.
    Kruse W; Kruse W; Raetzer H; Heuck CC; Oster P; Schellenberg B; Schlierf G
    Eur J Clin Pharmacol; 1979 Aug; 16(1):11-5. PubMed ID: 499296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of reducing circulating free fatty acids on ventricular arrhythmias during myocardial infarction and on ST-segment depression during exercise-induced ischemia.
    Oliver MF; Rowe MJ; Luxton MR; Miller NE; Neilson JM
    Circulation; 1976 Mar; 53(3 Suppl):I210-3. PubMed ID: 767017
    [No Abstract]   [Full Text] [Related]  

  • 35. The influence of intravenous injection of heparin and nicotinic acid on (GG) plasma glyceride-glycerol and free fatty acids (FFA) level.
    Ruzyllo E; Szostak WB; Olszak W
    Pol Med Sci Hist Bull; 1968 Apr; 11(2):52-3. PubMed ID: 5649940
    [No Abstract]   [Full Text] [Related]  

  • 36. Control of ventricular arrhythmias during myocardial infarction by antilipolytic treatment using a nicotinic-acid analogue.
    Rowe MJ; Neilson JM; Oliver MF
    Lancet; 1975 Feb; 1(7902):295-300. PubMed ID: 46951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A double-blind cross-over trial of a new hypolipidaemic drug (author's transl)].
    Proto C; Quadri A; Ratti S; Levi GF; Prandini BD
    G Ital Cardiol; 1978; 8(7):743-51. PubMed ID: 355033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of the combination of nicotinic acid and propranolol in very low doses on blood lipids in man.
    Avogaro P; Capri C; Cazzolato G; Pais M; Trabuio GF
    Atherosclerosis; 1974; 20(2):395-400. PubMed ID: 4369975
    [No Abstract]   [Full Text] [Related]  

  • 39. Editorial: Results of the coronary drug project--an interpretation.
    Carlson LA; Rössner S
    Atherosclerosis; 1975; 22(3):317-23. PubMed ID: 1106450
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of 3-carboxyl-5-methylpyrazole (CMP) on serum and liver lipids in rats.
    Tamási G; Borsy J; Patthy A
    Med Pharmacol Exp Int J Exp Med; 1967; 16(6):573-8. PubMed ID: 6072435
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.